Early studies suggest that this peptide – a dual stimulator of incretin and a related hormone receptors – offers a significant advance in weight reduction therapies. Unlike existing treatments , this dual-action compound shows to affect hunger and metabolic expenditure through distinct routes. Although more investigation is essential, current